Mutagenesis, Vol. 16, No. 3, 209-212,
May 2001
© 2001 UK Environmental Mutagen Society/Oxford University Press
Increased formation of micronuclei after hormonal stimulation of cell proliferation in human breast cancer cells
Department of Toxicology, University of Würzburg, Versbacher Strasse 9, D-97078 Würzburg, Germany
The carcinogenicity of sex hormones is considered to be the result of a combination of genotoxic and epigenetic modes of action. For estrogens, genotoxic activities include DNA damage by reactive metabolites and indirect genotoxicity by redox cycling and production of reactive oxygen species. Here, we present data on the induction of micronuclei in estrogen receptor-positive (MCF-7) and -negative (MDA) human breast cancer cell lines treated with estradiol to support an additional mechanism of chromosomal damage. MCF-7 cells, but not MDA cells, treated with estradiol in the picomolar concentration range showed an increase in micronucleus formation which correlated with the estradiol-induced cell proliferation. Addition of the specific estradiol-receptor antagonist hydroxytamoxifen suppressed the estradiol-induced formation of micronuclei in MCF-7 cells. Increased frequencies were also seen after normalization of the data to the number of cell divisions by additional treatment of the cells with cytochalasin B. Thus, formation of micronuclei was not due to the chromosomal damaging activity of estradiol. The induced genomic damage may be explained by a hormone-specific forcing of responsive cells through the cell cycle, thereby overriding checkpoints operating under homeostatic control of the cell cycle.
1 To whom correspondence should be addressed. Tel: +49 931 201 3427; Fax: +49 931 201 3446; Email: stopper{at}toxi.uni-wuerzburg.de
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  A. Kabil, E. Silva, and A. Kortenkamp Estrogens and genomic instability in human breast cancer cells--involvement of Src/Raf/Erk signaling in micronucleus formation by estrogenic chemicals Carcinogenesis, October 1, 2008; 29(10): 1862 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O Torres-Bugarin, R Covarrubias-Bugarin, A L Zamora-Perez, B M G Torres-Mendoza, M Garcia-Ulloa, and F G Martinez-Sandoval Anabolic androgenic steroids induce micronuclei in buccal mucosa cells of bodybuilders Br. J. Sports Med., September 1, 2007; 41(9): 592 - 596. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. I. Kalantzi, R. Hewitt, K. J. Ford, L. Cooper, R. E. Alcock, G. O. Thomas, J. A. Morris, T. J. McMillan, K. C. Jones, and F. L. Martin Low dose induction of micronuclei by lindane Carcinogenesis, April 1, 2004; 25(4): 613 - 622. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Stopper, E. Schmitt, C. Gregor, S. O. Mueller, and W. H. Fischer Increased cell proliferation is associated with genomic instability: elevated micronuclei frequencies in estradiol-treated human ovarian cancer cells Mutagenesis, May 1, 2003; 18(3): 243 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Davis, S. Bhana, A. J. Shorrocks, and F. L. Martin Oestrogens induce G1 arrest in benzo[a]pyrene-treated MCF-7 breast cells whilst enhancing genotoxicity and clonogenic survival Mutagenesis, September 1, 2002; 17(5): 431 - 438. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Yared, T. J. McMillan, and F. L. Martin Genotoxic effects of oestrogens in breast cells detected by the micronucleus assay and the Comet assay Mutagenesis, July 1, 2002; 17(4): 345 - 352. [Abstract] [Full Text] [PDF]
|
|